Mass-spectrometry-based clinical proteomics--a review and prospective. - Wikidata - wikimedia - TriplyDB

Mass-spectrometry-based clinical proteomics--a review and prospective.

Mass-spectrometry-based clinical proteomics--a review and prospective.

http://www.wikidata.org/entity/Q34252113

about

Bioanalytical chemistry of cytokines--a review Mass Spectrometry-Based Metabolomic and Proteomic Strategies in Organic Acidemias Network generation enhances interpretation of proteomics data sets by a combination of two-dimensional polyacrylamide gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight mass spectrometry.Targeted discovery and validation of plasma biomarkers of Parkinson's disease.Parallel deep transcriptome and proteome analysis of zebrafish larvae Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes The impact of growth hormone on proteomic profiles: a review of mouse and adult human studies."The quest for biomarkers": are we on the right technical track?Association between protein signals and type 2 diabetes incidence Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics.Ensembles of protein termini and specific proteolytic signatures as candidate biomarkers of disease.Peptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification.Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications.A new sample preparation method for the absolute quantitation of a target proteome using (18)O labeling combined with multiple reaction monitoring mass spectrometry.Paper spray ionization devices for direct, biomedical analysis using mass spectrometry.Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.Accuracy and Reproducibility in Quantification of Plasma Protein Concentrations by Mass Spectrometry without the Use of Isotopic Standards The proteomic profile of circulating pentraxin 3 (PTX3) complex in sepsis demonstrates the interaction with azurocidin 1 and other components of neutrophil extracellular traps Review, evaluation, and discussion of the challenges of missing value imputation for mass spectrometry-based label-free global proteomics Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS.Addressing the needs of traumatic brain injury with clinical proteomics.High-content affinity-based proteomics: unlocking protein biomarker discovery.Five years later: the current status of the use of proteomics and transcriptomics in EMF research.Potential biomarkers for early detection of acute graft-versus-host disease.Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.Nutriproteomics: facts, concepts, and perspectives.Current trends in magnetic particle enrichment for mass spectrometry-based analysis of cardiovascular protein biomarkers.Urine biomarkers for necrotizing enterocolitis.Current trends in quantitative proteomics - an update.Absolute quantitation of disease protein biomarkers in a single LC-MS acquisition using apolipoprotein F as an example.Bottom-Up Mass Spectrometry-Based Proteomics as an Investigative Analytical Tool for Discovery and Quantification of Proteins in Biological Samples.ExSTA: External Standard Addition Method for Accurate High-Throughput Quantitation in Targeted Proteomics Experiments.Peptide and Protein Quantification Using Automated Immuno-MALDI (iMALDI).Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma.Multiplexed longitudinal measurement of protein biomarkers in DBS using an automated SISCAPA workflow.A simple dual online ultra-high pressure liquid chromatography system (sDO-UHPLC) for high throughput proteome analysis.Comparison of standard- and nano-flow liquid chromatography platforms for MRM-based quantitation of putative plasma biomarker proteins.

P2860

Q26851317-8F99E77E-0956-4BC9-9BD9-FDFBFFC415E1 Q28077293-0C9E274A-7816-4842-BB35-56DDF3AAFF31 Q30561325-1387EF7A-231A-4729-A87E-92E18E2B53C1 Q30597182-63F278A6-EDDA-45A4-9851-D78EEF18E64F Q33590886-AC0964C0-4C7C-4186-B780-6B665A32AD90 Q33643266-D6881F23-E2B2-422C-A283-4087A77A9C1C Q33857579-CBC41A0B-D0B1-4010-90F1-3F06DCEC24B4 Q34116103-D825ED3F-3CC2-4FBC-AEB2-A70218CE8B15 Q34152210-05C4CA4D-61EB-4AF9-A242-DBACB4FCDEB5 Q34292436-2BC82D1D-9C40-4E91-B506-DD85CF6BD607 Q34402330-2E02D60E-4E78-4720-BED2-91B70A820C57 Q35264312-BF75F52F-9DD1-4BCB-ACFC-6CFAC8A90532 Q35518214-519F736A-F63C-472E-A911-C1C2D411A548 Q35539755-20F809BD-36C6-4385-BE59-B779C1F8FA7D Q35763392-DBF35823-ACAC-43B3-BED9-C633EFD766F9 Q36031629-56A1B23B-0009-456E-9CE2-C7FB47C199BC Q36170999-5BE11F7D-23B6-4538-B352-3415F1FB1A64 Q36209095-2C60E993-0401-40ED-9005-EFA8C2CEF005 Q36647475-391EA59D-B7E1-4CC0-9775-7E5FAF9E60A3 Q36795884-350F8882-6F51-4663-A9C3-7FCAE9F81B9C Q37685775-34A1CA01-61C3-4DC3-B15D-9C3ED0FD4AB5 Q37809868-059F676C-FEF2-4A44-998A-4234DC40F360 Q38019477-C371164D-25D8-4507-A2AC-0919195DE97B Q38038568-7657601C-546B-457D-BA76-C2F05B659EE4 Q38203040-1FEF1BD0-AEB0-47D6-A549-052D6BF0E092 Q38283156-6F5A607B-E35E-4209-807A-52310B395996 Q38364469-19F3DA8A-A3B5-4BA0-9844-7A870B563624 Q38390624-7C8B0A18-C108-442F-AF96-D5104C6AD16F Q38832695-461F2264-45ED-4CEB-8E2B-C4F075080E77 Q42152220-E8267BAB-F3F1-496B-A411-509E8522F1BF Q42862273-801F2FDB-85FA-44B7-94D5-4775B65F0B41 Q47818859-EB2BF4D0-CD48-4BA5-AA0A-8DAB84840A62 Q47855872-3E797379-3E5F-4F06-8096-75EBDE1CD161 Q51064892-B116B508-AF45-44E0-B723-B3D8B108F868 Q51639568-8FB17367-B0D0-4AEB-A539-D8628DAC8927 Q53208198-9FCCC30C-73F6-4A7A-82FE-1D67ADD4FDCC Q53378200-0EF689D4-DCC4-49D7-B6DA-CB04DDECDA3C

P2860

Mass-spectrometry-based clinical proteomics--a review and prospective.

http://www.wikidata.org/entity/Q34252113

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Mass-spectrometry-based clinical proteomics--a review and prospective.

@ast

Mass-spectrometry-based clinical proteomics--a review and prospective.

@en

Mass-spectrometry-based clinical proteomics--a review and prospective.

@nl

type

label

Mass-spectrometry-based clinical proteomics--a review and prospective.

@ast

Mass-spectrometry-based clinical proteomics--a review and prospective.

@en

Mass-spectrometry-based clinical proteomics--a review and prospective.

@nl

prefLabel

Mass-spectrometry-based clinical proteomics--a review and prospective.

@ast

Mass-spectrometry-based clinical proteomics--a review and prospective.

@en

Mass-spectrometry-based clinical proteomics--a review and prospective.

@nl

P1433

Q34252113-40251B50-99E3-4813-96DB-AE93A933EE90

P1476

Q34252113-EA6142EC-301C-4201-B247-C4F4595D5E3E

P2093

Q34252113-3454D128-C4AC-44DA-8BD2-E4529797E5F7

Q34252113-4D6DD4C0-1412-466F-AD33-772BBB7C4800

Q34252113-ADB48E68-EE82-49E9-9C30-3CE6B447A5EA

Q34252113-E2FC8207-5D46-47B2-AB66-A7E79A9DB15F

P2860

Q34252113-01E7E1BF-90CD-4547-B57C-E25BC565E161

Q34252113-03B4D818-52B8-4A1A-8FC2-45AF703FBE3A

Q34252113-058EC852-B2D1-476D-9001-7ECCDB632D5B

Q34252113-095E1332-5695-42DE-A5B4-101C2853954B

Q34252113-0AF85CE1-D22B-4266-A12C-E490F4AB4722

Q34252113-0B3103B6-D25D-4C2D-841F-7B581803D269

Q34252113-0B8C835A-CF21-428E-B8F6-0D0E8837C019

Q34252113-0CC08A39-3AFC-48A6-B33E-05E921FCA32F

Q34252113-154C9C98-F806-4AB8-BE93-FFA2920A38C6

Q34252113-1641F4D2-D48C-47C6-ABC8-ACFE461FAB73

P304

Q34252113-07B51592-0E9E-4493-B2E4-7ACE259BE0BF

P31

Q34252113-BE4FB637-98CA-4543-A691-A78474E52952

P356

Q34252113-D8E59927-559B-4AB2-A4D9-D1304070BBEA

P433

Q34252113-57AE0383-EFAD-436F-A06C-DFF909CF7F1E

P478

Q34252113-1A49D588-9FE9-499A-9A84-7D113E98D337

P577

Q34252113-9344FC65-1B68-47CE-BB90-6873EEE8072A

P5875

Q34252113-63F053A6-2E52-4016-88B7-CCA4050F9595

P698

Q34252113-21883925-0F99-4A3B-BB4F-B2C576E16F3F

P932

Q34252113-EA538058-904A-481E-94C8-657A925ABE9E

P356

P1433

P1476

Mass-spectrometry-based clinical proteomics--a review and prospective.

@en

P2093

Carol E Parker

http://www.w3.org/2001/XMLSchema#string

Christoph H Borchers

http://www.w3.org/2001/XMLSchema#string

N Leigh Anderson

http://www.w3.org/2001/XMLSchema#string

Terry W Pearson

http://www.w3.org/2001/XMLSchema#string

P2860

Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS

Comparative phenotypic analyses of human plasma and urinary retinol binding protein using mass spectrometric immunoassay

Ambient mass spectrometry using desorption electrospray ionization (DESI): instrumentation, mechanisms and applications in forensics, chemistry, and biology

Mass spectrometry sampling under ambient conditions with desorption electrospray ionization

MALDI imaging mass spectrometry: state of the art technology in clinical proteomics.

SISCAPA peptide enrichment on magnetic beads using an in-line bead trap device.

Determination of beta-2 microglobulin levels in plasma using a high-throughput mass spectrometric immunoassay system.

Desorption-ionization mass spectrometry on porous silicon.

Current trends in quantitative proteomics.

Towards the development of an immuno MALDI (iMALDI) mass spectrometry assay for the diagnosis of hypertension.

P304

1830-1838

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C0AN00105H

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44646981

http://www.w3.org/2001/XMLSchema#string

P698

20520858

http://www.w3.org/2001/XMLSchema#string

P932

2966304

http://www.w3.org/2001/XMLSchema#string